InsidersTradesSigma
Qiagen N.V.: insider trades · Netherlands · AFM
AFM:qiagen-nvNL·AFMMcap 9.8Bn€
Discover the full insider trade history of Qiagen N.V., a listed issuer based in Netherlands. Shares are listed on NL NL, under the supervision of AFM. Market capitalisation: €9.8bn. The latest transaction was reported on 12 May 2026 — Purchase. Among the most active insiders: R. Sackers. Every trade is free.
346
Insider Decl.
0
Thresholds
€1bn
89 ops.
Buy Volume
€187m
95 ops.
Sell Volume
Financial data
32.98 €
Income statement
Revenue2.09 Bn€
Gross profit1.30 Bn€62% margin
Net income424.9 M€20.3% margin
Balance sheet & cash
Market cap9.75 Bn€
Total debt1.81 Bn€
Free Cash Flow447.2 M€
Last declaration on 12 May 2026
Declarations346 total
Executives●Purchase9AFM
60,000 shares
Gewoon aandeel
AFM:193511·
Ideal exit: 6 Feb 2027 (T+270)
Executives●Mixed9AFM
-900 shares
Restricted share award
AFM:188993·
Executives●Mixed9AFM
-4,705 shares
Restricted share award
AFM:188999·
Executives●Mixed9AFM
-67,723 shares
Restricted share award
AFM:188955·
Executives●Mixed9AFM
-119,695 shares
Restricted share award
AFM:188984·
Executives●Mixed9AFM
-5,990 shares
Restricted share award
AFM:189031·
Executives●Mixed9AFM
-5,990 shares
Restricted share award
AFM:189028·
Executives●Mixed9AFM
-9,156 shares
Restricted share award
AFM:189030·
Executives●Mixed9AFM
-5,990 shares
Restricted share award
AFM:189026·
Executives●Purchase9AFM
4,618 shares
Restricted share award
AFM:189015·
Ideal exit: 24 Nov 2026 (T+270)
Executives●Purchase9AFM
4,618 shares
Restricted share award
AFM:189013·
Ideal exit: 24 Nov 2026 (T+270)
Executives●Purchase9AFM
70,305 shares
Restricted share award
AFM:189016·
Ideal exit: 24 Nov 2026 (T+270)
Executives●Purchase9AFM
4,618 shares
Restricted share award
AFM:189005·
Ideal exit: 24 Nov 2026 (T+270)
Executives●Purchase9AFM
4,618 shares
Restricted share award
AFM:189011·
Ideal exit: 24 Nov 2026 (T+270)
Executives●Purchase9AFM
4,618 shares
Restricted share award
AFM:189014·
Ideal exit: 24 Nov 2026 (T+270)
Executives●Mixed9AFM
-4,490 shares
Restricted share award
AFM:188864·
Executives●Mixed9AFM
-2,107 shares
Restricted share award
AFM:188861·
25 of 346 declarations
About Qiagen N.V.
Qiagen N.V. is a company specializing in molecular biology technologies, providing solutions for diagnostics and research. It is listed on the Amsterdam Stock Exchange.
